Research StudiesMedicine

Hematology/Oncology

Principal Investigator Title
Cigler, Tessa Multi-Center Study of Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women with Early-Stage Breast Cancer and Lymphoma
Elstrom, Rebecca Phase I/II Study of Combination Veltuzumab (anti-CD20) and Fractionated 90Y- Epratuzumab (Anti-CD22) Radioimmunotherapy in Patients with Follicular Lymphoma
Marcus, Aaron Thromboregulatin in Occlusive Vascular Diseases
Mark, Tomer Lenalidomide plus Melphalan as a Preparative Regimen for Autologous Stem Cell Transplantation in Relapsed or Refractory Multiple Myeloma: A Phase 1 / 2 Study
Nanus, David CALGB 90202: A Randomized Double-Blind, Placebo-Controlled Phase III Study of Early Versus Standard Zoeldronic Acid to Prevent Skeletal Related Events in Men with Prostate Cancer Metastatic to Bone
Schneider, Bryan Phase I study of Epigenetic Priming Using Azacitidine with Neoadjuvant Chemotherapy in Patients with Resectable Esophageal Cancer
Schneider, Bryan Phase I Study of Epigenetic Priming using Azacitidine in pts with Esophageal Cancer
Tagawa, Scott CALGB 90601: A Randomized Double-Blinded Phase III Study comparing Gemcitabine, Cisplatin, and Bevacizumab to Gemcitabine, Cisplatin, and Placebo in Patients with Advanced Transitional Cell Carcinoma
Tagawa, Scott A Randomized Phase 2 Trial of 177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and ketoconazole in Patients with High-Risk Castrate Biochemically Relapsed Prostate Cancer After Local Therapy
Tagawa, Scott A Phase I Trial of Docetaxel/Prednisone Plus Fractionated 177Lu-J591 Anti-prostate-specific Membrane Antigen Monoclonal Antibody in Patients with Metastatic, Castrate-resistant Prostate Cancer
Tagawa, Scott 177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) in Patients with Nonprostate Metastatic Solid Tumors: A Pilot Study
Tagawa, Scott Serum Markers of Neuroendocrine Differentiation in Prostate Cancer
Tagawa, Scott Radioimmunotherapy Dose-Escalation Studies in Prostate Cancer using 177Lu-J591 antibody: Dose Fractionation Regimen
Tagawa, Scott Phase II Trial of 177 Lutetium Radiolabeled Monoclonal Antibody Hu-J591-GS (177Lu-J591) in Patients with Metastatic Castrate Resistant Prostate Cancer
Tagawa, Scott CALGB 90802: Randomized Phase III Trial Comparing Everolimus Versus Everolimus Plus Bevacizumab for Advanced Renal Cell Carcinoma Progressing After Treatment with Tyrosine Kinase Inhibitors
Vahdat, Linda A Phase II Study of Tetrathiomolybdate (TM) in Patients with Breast Cancer at Moderate to High Risk of Recurrence
Wilkin, Timothy A5240: A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Wilkin, Timothy A5258: A Phase II, Double Blind, Randomized, Exploratory Study of Chloroquine for Reducing HIV-Associated Immune Activation
Wilkin, Timothy A5251: A Randomized Trial of Enhanced Nursing Telephone Support to Improve Medication Self-Management and Viral Outcomes of ART-Experienced Patients
Wilkin, Timothy A5298: A Randomized, Double-Blinded, Placebo-Controlled, Phase III Trial of the Quadrivalent HPV Vaccine to Prevent Anal Human Papillomavirus Infection in HIV-Infected Men and Women
Wilkin, Timothy AMC 076: A Randomized Clinical Trial of Infrared Coagulator (IRC) Ablation versus Expectant Management of Intra-Anal High Grade Intraepithelial Neoplasia (HGAIN) in HIV-infected Adults
Wilkin, Timothy INSIGHT 001: Strategic Timing of AntiRetroviral Treatment (START)